Acamprosate in the Treatment of Binge-Eating Disorder.

Trial Profile

Acamprosate in the Treatment of Binge-Eating Disorder.

Phase of Trial: Phase II/III

Latest Information Update: 21 Jun 2011

At a glance

  • Drugs Acamprosate (Primary)
  • Indications Binge-eating disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jun 2011 Actual end date (Jan 2011) added as reported by
    • 21 Jun 2011 Status changed from active, no longer recruiting to completed as reported by
    • 04 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top